Template:Neonatal HSV antivirals: Difference between revisions
(minor edits to the initial - added meds for SBI eval (i.e. febrile neonate) - broadened options for ocular coverage) |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
*[[Acyclovir]] 20 mg/kg IV every 8 hours (duration depends on classification) | |||
*If ocular involvement: | *If ocular involvement: | ||
**1% trifluridine, 0.1% iododeoxyuridine, or 3% vidarabine | **1% trifluridine, 0.1% iododeoxyuridine, or 3% vidarabine | ||
**Optho consult | **Optho consult | ||
*As for any febrile neonate SBI evaluation: | *As for any febrile neonate SBI evaluation: | ||
**Ampicillin + gentamycin | **[[Ampicillin]] + [[gentamycin]] | ||
***May substitute gentamycin with cefotaxime/ceftazidime | ***May substitute [[gentamycin]] with [[cefotaxime]]/[[ceftazidime]] | ||
Latest revision as of 04:00, 4 July 2016
- Acyclovir 20 mg/kg IV every 8 hours (duration depends on classification)
- If ocular involvement:
- 1% trifluridine, 0.1% iododeoxyuridine, or 3% vidarabine
- Optho consult
- As for any febrile neonate SBI evaluation:
- Ampicillin + gentamycin
- May substitute gentamycin with cefotaxime/ceftazidime
- Ampicillin + gentamycin